Skip to content ⤶ Skip to footer ⤶

Supporting those receiving immunotherapy by supporting those delivering it

IOCN Support health care professionals delivering immuno-oncology therapies to improve patient care through clinical support, education, service development and governance

Pillar 1

Education and Training

Providing education and training opportunities in Immuno-Oncology therapeutics and the autoimmune side effects.

Read More

Pillar 2

Clinical Support

Uniting experts in the field of Immuno- Oncology to disseminate clinical knowledge and experience to the broader oncology community.

Read More

Pillar 3

Service Development

Helping healthcare professionals develop services with a focus on managing of the auto-immune side effects.

Read More

Pillar 4

Research and Analysis

Promotion and support research or any activities that will progress our knowledge of immuno-oncology treatments and the auto-immune side effects.

Read More

Pillar 5

Policy and Governance

Collaborating with organisations and charities to support healthcare professionals develop Immuno- oncology policies and governance strategies.

Read More

    IOCN Webinars and Upcoming Events

    We are dedicated to providing accessible education for healthcare professionals across a broad range of immuno-oncology topics.

    Our offerings include free webinars, educational resources, and in-person study days.

    Find out more and sign up here!

    What we do

    The Immuno-Oncology Clinical Network (IOCN) is a charity that strives to improve the care of cancer patients receiving immuno-oncological (IO) treatments. We do this through supporting healthcare professionals by providing education and clinical support alongside support with key policy and governance subjects around IO treatments, research and service development.

    Continue Reading

    About us

    The Immuno-Oncology Clinical Network was established in 2022 by Dr Anna Olsson-Brown and a team of trustees with a passion for improving the care of cancer patients receiving immunotherapy treatment.

    Education and Training

    The IOCN team is passionate about providing education and training to healthcare professionals on all aspects of immune-oncology (IO) treatments, including the recognition and management of immune-mediated side effects. We provide healthcare professionals with a variety of educational offerings, including in-person events, free webinars, and podcasts.

    Join us

    Become a member of the IOCN to connect with a network of healthcare professionals and gain access to exclusive content, including educational events, free webinars, the latest news, and more.

    The Immunobuddies Podcast

    Ricky Frazer and Anna Olsson-Brown with guests discuss the dilemmas, challenges and progress made in the management of patients receiving immunotherapies to treat cancer.

    Upcoming News

    There are 9 posts for you to peruse.

    03.10.25

    IOCN Event - Advance the management of immunotherapy toxicities through case conundrums

    IOCN Event - Advance the management of immunotherapy toxicities through case conundrums

    12.09.25

    Survey: Fertility and the Use of Immune Checkpoint Inhibitor Therapy

    The purpose of this questionnaire is to detect variation and consistency across UK oncology practice in regards to managing patients of childbearing age who are planned for, or have previously received immune checkpoint inhibitor (ICI) therapy

    01.08.25

    Deadline Extended: Submit Your Abstract for the IOCN Advance the Management of Immunotherapy Toxicities through Case Conundrums Study Day!

    Deadline Extended for Abstract Submission to IOCN Study Day! Submit until Friday 22nd August!